Showing results (321-330 of 358) with videos related to

Sort By:
Pageof 36
Nature Communications|March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint InhibitorsSherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Journal for Immunotherapy of Cancer|May 7, 2021
Progesterone promotes immunomodulation and tumor development in the murine mammary glandLauryn R Werner, Katelin A Gibson, Merit L Goodman, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systemsNick Strayer, Tess Vessels, Karmel Choi, et al.
Cancer Immunology Research|May 13, 2022
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast CancerKyung-Min Lee, Chang-Ching Lin, Alberto Servetto, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized TrialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialRadha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
Pageof 36